<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.thepeptidenewsroom.com/the-gila-monster-peptide-behind-ozempic-and-what-the-venom-actually-contributed/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15</news:publication_date>
      <news:title>The Gila Monster Peptide Behind Ozempic, and What the Venom Actually Contributed</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/danish-registry-study-links-glp-1-drugs-to-preterm-birth-but-only-in-diabetes-pa/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-15</news:publication_date>
      <news:title>Danish Registry Study Links GLP-1 Drugs to Preterm Birth, But Only in Diabetes Patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/rogan-says-retatrutide-beats-glp-1-drugs-on-muscle-but-he-is-not-a-clinician/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14</news:publication_date>
      <news:title>Rogan Says Retatrutide Beats GLP-1 Drugs on Muscle, But He Is Not a Clinician</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/nad-is-selling-fast-in-skincare-and-telehealth-but-the-trial-data-is-missing/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14</news:publication_date>
      <news:title>NAD+ Is Selling Fast in Skincare and Telehealth, But the Trial Data Is Missing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/hhs-opens-six-unproven-peptides-to-compounding-pharmacies-but-no-regulator-will-/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14</news:publication_date>
      <news:title>HHS Opens Six Unproven Peptides to Compounding Pharmacies, But No Regulator Will Check Them</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/doctor-points-to-bone-density-as-collagens-underrated-angle-but-the-evidence-sec/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-14</news:publication_date>
      <news:title>Doctor Points to Bone Density as Collagen's Underrated Angle, But the Evidence Section Is Thin</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/purity-percentages-alone-dont-make-a-research-peptide-reliable-worldhealth-net-e/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>Purity Percentages Alone Don't Make a Research Peptide Reliable, WorldHealth.net Explainer Argues</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/peptide-combination-trial-reports-walking-gains-after-complete-spinal-cord-injur/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>Peptide Combination Trial Reports Walking Gains After Complete Spinal Cord Injury, But Data Remain Preliminary</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/hhs-draft-policy-names-kpv-among-six-compounding-peptides-but-it-is-not-fda-appr/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>HHS Draft Policy Names KPV Among Six Compounding Peptides, But It Is Not FDA Approval</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/dj-khaled-says-a-glp-1-helped-him-lose-90-pounds-but-the-record-stops-there/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>DJ Khaled Says a GLP-1 Helped Him Lose 90 Pounds, But the Record Stops There</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/china-clears-lillys-muyouda-as-first-oral-non-peptide-weight-loss-pill-beating-n/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>China Clears Lilly's Muyouda as First Oral Non-Peptide Weight-Loss Pill, Beating Novo to Market</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/ama-urges-hhs-to-rescind-peptide-compounding-policy-as-bpc-157-comment-window-cl/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-13</news:publication_date>
      <news:title>AMA Urges HHS to Rescind Peptide Compounding Policy as BPC-157 Comment Window Closes</news:title>
    </news:news>
  </url>
</urlset>